Our Head of Assay Feasibility, Dr John Tyson presented an e-poster at ECCVID last month – the ESCMID Conference on Coronavirus.
The e-poster focuses on the independent, multi centre, clinical performance evaluation of QuantuMDx’ SARS-CoV-2 RT-PCR Detection Assay.
For media enquiries, please contact:
Debra Daglish, Marketing Communications Manager, QuantuMDx Group
